Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography

Douglas R. Davies, Bjorn Mamat, Olafur T. Magnusson, Jeff Christensen, Magnus H. Haraldsson, Rama Mishra, Brian Pease, Erik Hansen, Jasbir Singh, David Zembower, Hidong Kim, Alex S. Kiselyov, Alex B. Burgin, Mark E. Gurney, Lance J. Stewart

Research output: Contribution to journalArticlepeer-review

92 Scopus citations


We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein-protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors.

Original languageEnglish (US)
Pages (from-to)4694-4715
Number of pages22
JournalJournal of Medicinal Chemistry
Issue number15
StatePublished - Aug 13 2009

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography'. Together they form a unique fingerprint.

Cite this